Bluejay Diagnostics Inc

NASDAQ:BJDX   2:22:35 PM EDT
0.45
-0.08 (-15.09%)
Earnings Announcements

Bluejay Diagnostics Reports Third Quarter Results

Published: 11/09/2022 14:46 GMT
Bluejay Diagnostics Inc (BJDX) - Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results.
Bluejay Diagnostics Inc Q3 Loss per Share $0.15.
Bluejay Diagnostics Inc- Expects That Cash Position Will Be Sufficient to Fund Operations for Next 12 Months.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.04

Next Quarter Revenue Guidance is expected to be $0.81 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.